Ipilumab monoclonal antibody drug. Targets CTLA-4 (immune checkpoint inhibitor) and is used in the treatment of cancer. Generic name and stylized anti


Ipilumab monoclonal antibody drug. Targets CTLA-4 (immune checkpoint inhibitor) and is used in the treatment of cancer. Generic name and stylized antibody.


Size: 9000px × 4982px
Photo credit: © molekuul.be / Alamy / Afripics
License: Royalty Free
Model Released: No

Keywords: antibody, antigen, biological, biosimilar, biotech, biotechnology, blockade, cancer, checkpoint, combination, ctla-4, ctla4, cytotoxic, disease, drug, immune, immuno-oncology, immunoglobulin, immunology, immunotherapy, infusion, inhibitor, injection, inn, ipilumab, lymphocyte, lymphocyte-, mab, melanoma, monoclonal, neoantigen, nomenclature, oncology, peptide, protein, tumor